References
- Lundqvist H, Follin P, Khalfan L, Dahlgren C. Phorbol myristate acetate-induced NADPH oxidase activity in human neutrophils: only half the story has been told. J Leukoc Biol 1996; 59: 270–279.
- Dahlgren C, Karlsson A. Respiratory burst in human neutrophils. J Immunol Methods 1999; 232: 3–14.
- Karlsson A, Nixon JB, McPhail LC. Phorbol myristate acetate induces neutrophil NADPH-oxidase activity by two separate signal transduction pathways: dependent or independent of phosphatidylinositol 3-kinase. J Leukoc Biol 2000; 67: 396–404.
- Karlsson A, Dahlgren C. Assembly and activation of the neutrophil NADPH oxidase in granule membranes. Antioxid Redox Signal 2002; 4: 49–60.
- Kopprasch S, Gatzweiler A, Graessler J, Schroder H-E. Beta-adrenergic modulation of FMLP- and zymosan-induced intracellular and extracellular oxidant production by polymorphonuclear leukocytes. Mol Cell Biochem 1997; 168: 133–139.
- Lundqvist-Gustafsson H, Bengtsson T. Activation of the granule pool of the NADPH oxidase accelerates apoptosis in human neutrophils. J Leukoc Biol 1999; 65: 196–204.
- Kopprasch S, Pietzsch J, Graessler J. Validation of different chemiluminergic substrates for detecting extracellular generation of reactive oxygen species by phagocytes and endothelial cells. Luminescence 2003; 18: 268–273.
- Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res 2004; 61: 481–497.
- Edwards SW, Hallett MB. Seeing the wood for the trees: the forgotten role of neutrophils in rheumatoid arthritis. Immunol Today 1997; 18: 320–324.
- Bostan M, Galatiuc C, Hirt M, Constantin MC, Brasoveanu LI, Iordachescu D. Phospholipase A, modulates respiratory burst developed by neutrophils in patients with rheumatoid arthritis. J Cell Mol Med 2003; 7: 57–66.
- Ho K-J, Chen P-Q, Chang C-Y, Lu F-J. The oxidative metabolism of circulating phagocytes in ankylosing spodylitis: determination by whole blood chemiluminescence. Ann Rheum Dis 2000; 59: 338–341.
- Jancinova V, Nosal R, Drabikova K, Danihelova E. Cooperation of chloroquine and blood platelets in inhibition of polymorphonuclear leukocyte chemiluminescence. Biochem Pharmacol 2001; 62: 1629–1636.
- Navarro M, Vasquez F, Veldsquez M, Medina R, Reggio R, Fraile G. Effects of gold-chloroquine complexes on respiratory burst of polymorphonuclear leukocytes. Arzneimittelforschung 2002; 52: 468–474.
- Vargas F, Rivas C, Diaz Y et al. Antioxidant properties of dipyridamole as assessed by chemiluminescence. Pharmazie 2003; 58: 817–823.
- Yasunari K, Maeda K, Nakamura M, Watanabe T, Yoshikawa J, Asada A. Effects of carvedilol on oxidative stress in polymorphonuclear and mononuclear cells in patients with essential hypertension. Am J Med 2004; 116: 460–465.
- Nosál R, Jancinova V, Ciz M, Drabikova K, Lojek A, Fabryova V. Inhibition of chemiluminescence by carvedilol in the cell-free system, whole human blood and blood cells. Scand J Clin Lab Invest 2005; 65: 55–64.
- Pavelkova M, Kubala L. Luminol-, isoluminol- and lucigenin-enhanced chemiluminescence of rat blood phagocytes stimulated with different activators. Luminescence 2004; 19: 37–42.
- Lojek A, Kubala L, Cizova H, Ciz M. A comparison of whole blood neutrophil chemiluminescence measured with cuvette and microtitre plate luminometers. Luminescence 2002; 17: 1–4.
- Cizova H, Lojek A, Kubala L, Ciz M. The effect of intestinal ischemia duration on change plasma antioxidant defense status in rats. Physiol Res 2004; 53: 523–531.
- Lundqvist H, Dahlgren C. Isoluminol-enhanced chemiluminescence: a sensitive method to study the release of superoxide anion from human neutrophils. Free Radic Biol Med 1996; 20: 785–792.
- Faldt J, Ridell M, Karlsson A, Dahlgren C. The phagocyte chemiluminescence paradox: luminol can act as an inhibitor of neutrophil NADPH-oxidase activity. Luminescence 1999; 14: 153–160.
- Drabikova K, Nosal R, Jancinova V, Ciz M, Lojek A. Reactive oxygen metabolite production is inhibited by histamine and H1-antagonist dithiaden in human PMN leukocytes. Free Radic Res 2002; 36: 975–980.
- Rackova L, Majekova M, Kos-LA.1°yd D, Stefek M. Antiradical and antioxidant activities of alkaloids isolated from Mahonia aquifolium. Structural aspects. Bioorgan Med Chem 2004; 12: 4709–4715.
- Yahyapour N, Eriksson C, Kjellstrand P, Wieslander A, Nygren H. Protection by glutathione of neutrophils against the toxic effects of peritoneal dialysis fluid. Toxicol in Vitro 2001; 15: 655–661.
- Fredriksson MI, Gustafsson AK, Bergstrom KG, Asman BE. Constitutionally hyperreactive neutrophils in periodontitis. J Periodontol 2003; 74: 219–224.
- Zhang B, Hirahashi J, Cullere X, Mayadas TN. Elucidation of molecular events leading to neutrophil apoptosis following phagocytosis. Cross-talk between caspase 8, reactive oxygen species, and MAPK/ERK activation. J Biol Chem 2003; 278: 28443–28454.
- Dunn JS, Freed BM, Gustafson DL, Stringer KA. Inhibition of human neutrophil reactive oxygen species production and p67phox translocation by cigarette smoke extract. Atherosclerosis 2005; 179: 261–267.
- Nakamura M, Nakamura S. One- and two-electron oxidations of luminol by peroxidase systems. Free Radic Biol Med 1998; 24: 537–544.
- Lock R, Johansson A, Orselius K, Dahlgren C. Analysis of horseradish peroxidase-amplified chemiluminescence produced by human neutrophils reveals a role for the superoxide anion in the light emitting reaction. Anal Biochem 1988; 173: 450–455.
- Nosal R, Drabikova K, Jancinova V, Ciz M, Lojek A. Effect of the histaminergic system on human polymorphonuclear leukocyte aggregation and respiratory burst in vitro. In: Stanley PE, Kricka U. (eds) Bioluminescence & chemiluminescence. Progress & current applications. London: World Scientific, 2002; 285–288.
- Nosal R, Drabikova K, Ciz M, Lojek A, Danihelova E. Effect of Hi-antagonist Dithiaden on human PMN-leukocyte aggregation and chemiluminescence is stimulus-dependent. Inflamm Res 2002; 51: 557–562.
- Nosal R, Drabikova K, Jancinova V, Petrikova M, Fabryova V. Antiplatelet and antiphagocyte activity of H1-antihistamines. Inflamm Res 2005; 54 (Suppl 1): S19–S20.
- Assanasen P. Naclerio RM. Anti-allergic anti-inflammatory effects of HI-antihistamines in humans. Clin Allergy Immunol 2002; 17: 101–139.
- Brockman HL, Momsen MM, Knudtson JR, Miller ST, Graff G, Yanni JM. Interactions of olopatadine and selected antihistamines with model and natural membranes. Ocul Immunol Inflamm 2003; 11: 247–268.